CPhI: Dr. Reddy’s builds large-scale API facility in India

Dr. Reddy’s Laboratories (Hyderabad, India), the second largest API company in the world in terms of sales, after Teva, says that it will open a new large-scale active pharmaceutical ingredient (API) manufacturing facility at Visakhapatnam, India later this year. The current global API manufacturing operations of Dr. Reddy’s include six plants in India; one plant at Mirfield, UK; and a plant at Cuernavaca, Mexico. All the facilities are approved by the US FDA. “As we grow we need production capacity to support this growth. Later this year, we...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers